Tech Transfer eNews Blog
Industry-Sponsored Research Management sample issue

UAB licenses protein purification tech to TriAltus Bioscience


By Jesse Schwartz
Published: March 28th, 2018

The University of Alabama at Birmingham (UAB) has licensed a novel protein purification platform to TriAltus Bioscience, LLC, which is already working to commercialize the technology.

Demand for genetically engineered proteins is strong and growing quickly, yet production of the material used in many research labs is cumbersome and inefficient. Isolating the desired protein requires an average of four to five purification steps, and most of the protein is lost in the process.

The new purification method licensed by TriAltus works by isolating proteins in a single purification step, with ultra-high purity and producing yields 100 times greater than conventional methods.

“We had our first commercial sale less than a month after completing the agreement with UAB,” said Robert Shufflebarger, co-founder and CEO of TriAltus. “This is practically unheard of for a bioscience company, and speaks to the need in the market for a better solution.”

TriAltus has begun to raise Series A funding, and Shufflebarger reports that the company already has customers in four countries and will use the fundraising proceeds to increase production to meet demand.

“We are focused on identifying our best, most promising technologies and transitioning them into the marketplace,” said Kathy Nugent, PhD, executive director of UAB’s Bill L. Harbert Institute for Innovation and Entrepreneurship. “We believe that TriAltus is well-positioned to accomplish this.” 

Source: Benzinga

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment